secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2025-04-14T23:59:59+00:00
Accession:  0000950170-25-053715
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Q3 revenue $15.1M (+82% YoY); FY2025 guided $58-58.5M
------------------------------------------------------------

- Revenue $15.1M in Q3 FY2025, up 82% YoY; gross margin improved to 43.4% from 10.6%.
- GAAP net loss $21.8M vs $21.6M prior year; adjusted EBITDA loss $16.3M vs $16.2M.
- Completed IPO in March 2025, raising net proceeds of $205.2M.
- In-network covered lives for ASSURE system now exceed 285M; appointed Al Ford as CCO.
- FY2025 revenue outlook $58M to $58.5M, representing 109%-110% growth vs FY2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000095017025053715/0000950170-25-053715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000095017025053715/ck0001877184-20250414.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-053715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer